Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Precision BioSciences, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate 3.24% of over the last 5 years
2
The company has declared negative results for the last 2 consecutive quarters
- NET SALES(HY) At USD 0.03 MM has Grown at -99.94%
- NET PROFIT(HY) At USD -42.4 MM has Grown at -1,262.57%
- ROCE(HY) Lowest at -205.16%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 30.92%, its profits have fallen by -578.4%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Precision BioSciences, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Precision BioSciences, Inc.
30.92%
-0.65
72.18%
S&P 500
16.12%
0.77
19.29%
Quality key factors
Factor
Value
Sales Growth (5y)
-49.80%
EBIT Growth (5y)
3.24%
EBIT to Interest (avg)
-50.75
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.08
Sales to Capital Employed (avg)
0.72
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
77.39%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
9.38
EV to EBIT
-1.51
EV to EBITDA
-1.56
EV to Capital Employed
-30.63
EV to Sales
134.91
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-523.67%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Technical Movement
2What is working for the Company
OPERATING PROFIT(Q)
Highest at USD -19.99 MM
EPS(Q)
Highest at USD -1.84
-23What is not working for the Company
NET SALES(HY)
At USD 0.03 MM has Grown at -99.94%
NET PROFIT(HY)
At USD -42.4 MM has Grown at -1,262.57%
ROCE(HY)
Lowest at -205.16%
DEBT-EQUITY RATIO
(HY)
Highest at -94.64 %
RAW MATERIAL COST(Y)
Grown by 6,546.13% (YoY
CASH AND EQV(HY)
Lowest at USD 107.11 MM
DEBTORS TURNOVER RATIO(HY)
Lowest at 0.9 times
Here's what is working for Precision BioSciences, Inc.
Operating Profit
Highest at USD -19.99 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
EPS
Highest at USD -1.84
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Here's what is not working for Precision BioSciences, Inc.
Net Sales
At USD 0.03 MM has Grown at -99.94%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Net Profit
At USD -42.4 MM has Grown at -1,262.57%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Debt-Equity Ratio
Highest at -94.64 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Cash and Eqv
Lowest at USD 107.11 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio
Lowest at 0.9 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 6,546.13% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






